Psalion
28.7.2026 00:00:00 CEST | Globenewswire | Press release
Psalion Closes Its Largest Fund Yet to Back the Next Wave of Blockchain Adoption
Psalion Closes Its Largest Fund Yet to Back the Next Wave of Blockchain Adoption
SINGAPORE, July 27, 2026 (GLOBE NEWSWIRE) -- Psalion today announced the launch of its third and largest venture fund to date — a USD 50 million vehicle aimed at the next wave of blockchain adoption. The fund is structured as a Singapore-domiciled Variable Capital Company (VCC), managed by Conduit Asset Management Pte. Ltd. (CAM), which is licensed and regulated by the Monetary Authority of Singapore (MAS).
The new fund aims to potentially back founders bringing blockchain into the real economy across infrastructure, middleware, trade finance, real-world assets (RWA), stablecoins, and decentralised finance (DeFi), focusing on pre-seed and seed stage companies, with an eye on consumer applications where web3 rails are quietly reshaping how people own, trade, and interact with assets.
“Crypto was the thesis. The traditional financial system was the antithesis. What we’re investing in is the synthesis — where web2 businesses run on web3 rails,” said Tim Enneking, Managing Partner of Psalion.
Psalion’s previous two funds both launched in down markets — and the firm has no intention of changing that habit.
“Some of the best opportunities arise in down markets. Valuations are more reasonable, founders are more focused, and the builders who show up are in it for the long term,” Enneking added.
About Psalion
Psalion is a global digital asset investment manager focused on early-stage venture capital, yield strategies, and digital asset lending. Led by pioneers of the digital asset industry with decades of experience across traditional finance, asset management, and blockchain markets, Psalion serves institutions, family offices, corporate treasuries, allocators, and sophisticated investors seeking risk-aware access to digital asset opportunities.
Contact : notices@conduit.group
Disclaimer
This press release is for informational purposes only and does not constitute an offer to sell securities, an offer to invest, investment advice, tax advice or legal advice. The fund is available to accredited and institutional investors (as defined in the Securities and Futures Act 2001, as may be amended from time to time) only, subject to applicable laws and regulations. The fund is not authorised or recognised by the Monetary Authority of Singapore (MAS) and is offered only pursuant to the exemptions available under the Securities and Futures Act 2001, as may be amended from time to time. MAS assumes no responsibility for reviewing, verifying and approving the contents of this release along with any other associated documents. Past performance is not indicative of future results. Prospective investors should consult their own legal, tax and financial advisers before entering into any investment arrangement. The contents of this release may not be reproduced or referenced, either in part or in full, without the prior written permission of CAM.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
FireFly Metals Limited28.7.2026 01:50:00 CEST | Press release
Extremely high-grade copper-gold Core Zone to drive early production
Psalion28.7.2026 01:00:00 CEST | Press release
Psalion Backs Beezie in $4 Million Round to Reinvent How People Buy and Collect
ProMIS Neurosciences Inc.27.7.2026 22:00:00 CEST | Press release
ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease
Royal Philips27.7.2026 20:52:41 CEST | Press release
Philips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refund
Cosmos Health Inc.27.7.2026 19:05:00 CEST | Press release
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom